SCMP

Sucampo Pharmaceuticals, Inc. News Headlines

$13.57
*  
0.13
0.97%
Get SCMP Alerts
*Delayed - data as of Dec. 19, 2014  -  Find a broker to begin trading SCMP now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Emergent BioSolutions Buys EV-035 Series from Evolva - Analyst Blog
12/18/2014 4:45:00 PM - Zacks.com


UCB's Kremers Urban Sale Deal Lapses, Divestiture Plan On - Analyst Blog
12/18/2014 3:20:00 PM - Zacks.com


Emergent BioSolutions Buys EV-035 Series from Evolva - Analyst Blog
12/18/2014 4:45:00 AM - Investopedia


UCB's Kremers Urban Sale Deal Lapses, Divestiture Plan On - Analyst Blog
12/18/2014 3:20:00 AM - Investopedia


Cyclacel Falls on Poor Acute Myeloid Leukemia Drug Data - Analyst Blog
12/17/2014 5:00:00 PM - Zacks.com


Salix Gains on Destocking Initiatives, Gives 2-Year Outlook - Analyst Blog
12/17/2014 2:12:00 PM - Investopedia


Salix Gains on Destocking Initiatives, Gives 2-Year Outlook - Analyst Blog
12/17/2014 2:12:00 PM - Zacks.com


Cyclacel Falls on Poor Acute Myeloid Leukemia Drug Data - Analyst Blog
12/17/2014 5:00:00 AM - Investopedia


Alexion Announces New Share Repurchase Program of $500M - Analyst Blog
12/16/2014 6:55:00 PM - Zacks.com


Sophiris Plunges on Disappointing Data on its BPH Candidate - Analyst Blog
12/16/2014 4:30:00 PM - Zacks.com


Calithera Biosciences Slumps: CALA Tanks 10.4% in Session - Tale of the Tape
12/16/2014 8:50:00 AM - Zacks.com


Alexion Announces New Share Repurchase Program of $500M - Analyst Blog
12/16/2014 6:55:00 AM - Investopedia


One Stock Chart Trick You Should All Know - Investment Ideas
12/16/2014 1:00:00 AM - Zacks.com


ChemoCentryx Up on Positive Diabetic Nephropathy Data - Analyst Blog
12/15/2014 6:45:00 PM - Zacks.com


Astellas-Medivation Reveal Data on Xtandi for Breast Cancer - Analyst Blog
12/15/2014 3:00:00 PM - Zacks.com


One Stock Chart Trick You Should All Know - Investment Ideas
12/15/2014 1:00:00 PM - Investopedia


Cerulean Pharma (CERU) Worth Watching: Stock Rises 16.1% - Tale of the Tape
12/15/2014 9:39:00 AM - Zacks.com


Flexion Therapeutics (FLXN) Worth Watching: Stock Up 9.2% - Tale of the Tape
12/15/2014 9:25:00 AM - Zacks.com


ChemoCentryx (CCXI) Shows Strength: Stock Moves Up 24.7% - Tale of the Tape
12/15/2014 8:51:00 AM - Zacks.com


ChemoCentryx Up on Positive Diabetic Nephropathy Data - Analyst Blog
12/15/2014 6:45:00 AM - Investopedia


Shire Updates on Pipeline at Research & Development Day - Analyst Blog
12/11/2014 12:43:00 PM - Zacks.com


Dipexium (DPRX) Worth Watching: Stock Moves 7.8% Higher - Tale of the Tape
12/11/2014 9:46:00 AM - Zacks.com


Calithera Biosciences, Inc. (CALA) in Focus: Stock Soars 29.9% - Tale of the Tape
12/11/2014 9:18:00 AM - Zacks.com


Nektar/AstraZeneca's Moventig Gets EU Approval for OIC - Analyst Blog
12/10/2014 6:50:00 PM - Zacks.com


UCB Reports Phase III Data on Epilepsy Drug, To File in 2015 - Analyst Blog
12/9/2014 2:50:00 PM - Zacks.com